CA
25
-7
ROK
52
-2
DRI
48
3
YUM
47
-2
FLS
69
-2
EL
34
-3
NSC
37
-3
MNST
56
9
CSX
44
-2
PVH
60
2
FMC
37
-2
NFLX
74
-2
PDCO
74
-3
RL
75
3
WFC
58
-2
BWA
49
-6
MUR
34
-10
NDAQ
50
-6
EMR
64
-3
FLR
46
-2
CA
25
-7
ROK
52
-2
DRI
48
3
YUM
47
-2
FLS
69
-2
EL
34
-3
NSC
37
-3
MNST
56
9
CSX
44
-2
PVH
60
2
FMC
37
-2
NFLX
74
-2
PDCO
74
-3
RL
75
3
WFC
58
-2
BWA
49
-6
MUR
34
-10
NDAQ
50
-6
EMR
64
-3
FLR
46
-2
Financhill
Back

Abivax SA Quote, Financials, Valuation and Earnings

Zero Day Options Trade LIVE Tuesday at 2 p.m. ET!

Discover The Zero Day Loophole (BEFORE Tues at 2 p.m. ET!)
Buy
51

AAVXF
Abivax SA

Last Price:
11.05
Seasonality Move:
-7.57%

7 Day Trial

ALL ACCESS PASS

$ 7

The dark truth about AI

Click here to learn more...

Abivax SA Price Quote

$11.05

Abivax SA Key Stats

Buy
51
Abivax SA (AAVXF) is a Buy
Day range:
$11.05 - $11.05
52-week range:
$10.19 - $15.15
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0%
Volume:
0
Avg. volume:
0
1-year change:
8.44%
Market cap:
$695.2M
Revenue:
$0
EPS:
$-3.54

How Much Does Abivax SA Make?

Data Unavailable

Is Abivax SA Growing As A Company?

Data Unavailable

Abivax SA Stock Price Performance

  • Did Abivax SA Stock Go Up Last Month?
    Abivax SA share price went up by 0% last month
  • Did AAVXF's Share Price Rise Over The Last Year?
    AAVXF share price rose by 8.44% over the past 1 year

What Is Abivax SA 52-Week High & Low?

  • What Is Abivax SA’s 52-Week High Share Price?
    Abivax SA has traded as high as $15.15 over the past 52 weeks
  • What Is Abivax SA’s 52-Week Low Share Price?
    Abivax SA has traded as low as $10.19 over the past 52 weeks

Abivax SA Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Abivax SA?

  • How Much Debt Does Abivax SA Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Abivax SA Have?
    Cash and short term investments quarterly total is $288.5M
  • What Is Abivax SA’s Book Value Per Share?
    Book value per share is 3.44

Is Abivax SA Cash Flow Positive?

  • What Is AAVXF Cash Flow From Operations?
    Cash flow from operations (TTM) is -$104.9M
  • What Is Abivax SA’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $361M
  • What Is Abivax SA’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$8.8M

Abivax SA Return On Invested Capital

Data Unavailable

Abivax SA Earnings Date & Stock Price

  • What Is Abivax SA's Stock Price Today?
    A single share of AAVXF can be purchased today for 11.05
  • What Is Abivax SA’s Stock Symbol?
    Abivax SA trades on the otcm under the ticker symbol: AAVXF
  • When Is Abivax SA’s Next Earnings Date?
    The next quarterly earnings date for Abivax SA is scheduled on December 15, 2024
  • When Is AAVXF's next ex-dividend date?
    Abivax SA's next ex-dividend date is December 15, 2024
  • How To Buy Abivax SA Stock?
    You can buy Abivax SA shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Abivax SA Competitors

  • Who Are Abivax SA's Competitors?
    Below is a list of companies who compete with Abivax SA or are related in some way:
    • Cellectis SA (CLLS)
    • DBV Technologies SA (DBVT)
    • Genfit SA (GNFT)
    • Innate Pharma SA (IPHA)
    • Inventiva SA (IVA)

Abivax SA Dividend Yield

  • What Is AAVXF Dividend Yield?
    Abivax SA’s dividend yield currently is 0%
  • What Is Abivax SA’s Payout Ratio?
    Abivax SA’s payout ratio is 0%
  • When Did Abivax SA Last Pay A Dividend?
    The latest dividend pay date is December 15, 2024
  • What Is Abivax SA’s Dividend Per Share?
    Abivax SA pays a dividend of $0.00 per share

Abivax SA Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 0.00
Downside from Last Price: -100%

Major Shareholders

  • How many AAVXF shares are owned by institutional investors?
    1.1M AAVXF shares are owned by institutional investors
  • How many AAVXF shares are owned by insiders?
    0 AAVXF shares are owned by insiders